Confirmatory Study of BK1310 in Healthy Infants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of this study is to evaluate immunogenicity of BK1310 for all antigens (anti‐PRP, diphtheria toxin, pertussis, tetanus toxin, and polio virus), after 3 times of injection, when compared noninferiority with co‐administration of ActHIB® and Tetrabik, as well as efficacy and safety, in healthy infants.
Epistemonikos ID: 83782df3fd6d45f08b1bcc3a015306a9884c9994
First added on: May 22, 2024